Effects of nintedanib on circulating biomarkers in patients with progressive pulmonary fibrosis: subgroups by fibrotic pattern on HRCT

被引：0
|
作者：
Maher, Toby M. [1 ,2 ]
Bonella, Francesco [3 ]
Assassi, Shervin [4 ]
Noth, Imre [5 ]
Diefenbach, Claudia [6 ]
Ittrich, Carina [6 ]
Rohr, Klaus B. [7 ]
Kolb, Martin [8 ,9 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Duisburg Essen Univ, Ruhrlandklinik Univ Hosp, Ctr Interstitial & Rare Lung Dis, Essen, Germany
[4] Univ Texas Houston, Div Rheumatol, McGovern Med Sch, Houston, TX USA
[5] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[8] McMaster Univ, Hamilton, ON, Canada
[9] St Josephs Healthcare, Hamilton, ON, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2879
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of Nintedanib on Circulating Biomarkers in Patients With Progressive Pulmonary Fibrosis: Subgroup Analyses of the INBUILD Trial
    Maher, T. M.
    Jenkins, R. G.
    Bonella, F.
    Assassi, S.
    Noth, I.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K. B.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis
    Wijsenbeek, Marlies
    Swigris, Jeffrey J.
    Inoue, Yoshikazu
    Kreuter, Michael
    Maher, Toby M.
    Suda, Takafumi
    Baldwin, Michael
    Mueller, Heiko
    Rohr, Klaus B.
    Flaherty, Kevin R.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 63 (02)
  • [3] Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
    Kolb, Martin
    Flaherty, Kevin R.
    Silva, Rafael S.
    Prasse, Antje
    Vancheri, Carlo
    Mueller, Heiko
    Sroka-Saidi, Kamila
    Wells, Athol U.
    INBUILD Trial Investigators
    ADVANCES IN THERAPY, 2023, 40 (12) : 5536 - 5546
  • [4] Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
    Martin Kolb
    Kevin R. Flaherty
    Rafael S. Silva
    Antje Prasse
    Carlo Vancheri
    Heiko Mueller
    Kamila Sroka-Saidi
    Athol U. Wells
    Advances in Therapy, 2023, 40 : 5536 - 5546
  • [5] Prognostic value of circulating biomarkers in patients with progressive pulmonary fibrosis
    Bonella, Francesco
    Jenkins, R. Gisli
    Maher, Toby M.
    Assassi, Shervin
    Noth, Imre
    Diefenbach, Claudia
    Ittrich, Carina
    Rohr, Klaus B.
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern
    Dellaripa, Paul
    Aringer, Martin
    Mann-Vold, Anna Maria Hoff
    Kelly, Clive
    Mittoo, Shikha
    James, Alexandra
    Rohr, Klaus
    Stowasser, Susanne
    Inoue, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Effect of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis and Differing Extents of Emphysema on HRCT
    Cottin, V.
    Jacob, J.
    Sverzellati, N.
    Richeldi, L.
    Bendstrup, E.
    Stowasser, S.
    Lievens, D.
    Stansen, W.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] Circulating Biomarkers in Patients With Progressive Pulmonary Fibrosis: Data From the INBUILD Trial
    Noth, I.
    Maher, T. M.
    Bonella, F.
    Assassi, S.
    Jenkins, R. G.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K. B.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    RESPIRATORY RESEARCH, 2014, 15
  • [10] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Katrin E Hostettler
    Jun Zhong
    Eleni Papakonstantinou
    George Karakiulakis
    Michael Tamm
    Petra Seidel
    Qingzhu Sun
    Jyotshna Mandal
    Didier Lardinois
    Christopher Lambers
    Michael Roth
    Respiratory Research, 15
12345